The association of genomic alterations with PD‐L1 expression in Chinese patients with EGFR/ALK wild‐type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy

Documenti analoghi

• SMARCA4 mutations and expression in lung adenocarcinoma: prognostic significance and impact on the immunotherapy response
  di: Yuming Zhang, et al.
  Pubblicazione: (2024)
• Implications of intestinal microecology and immune function alterations for immunotherapy outcomes in advanced unresectable lung adenocarcinoma
  di: Shuang He, et al.
  Pubblicazione: (2024)
• Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR‐TKIs
  di: Zhenbang Gu, et al.
  Pubblicazione: (2024)
• Exploring Gene Regulatory Interaction Networks and predicting therapeutic molecules for Hypopharyngeal Cancer and EGFR-mutated lung adenocarcinoma
  di: Bhattacharjya, Abanti, et al.
  Pubblicazione: (2024)
• Exploring gene regulatory interaction networks and predicting therapeutic molecules for hypopharyngeal cancer and EGFR ‐mutated lung adenocarcinoma
  di: Abanti Bhattacharjya, et al.
  Pubblicazione: (2024)